Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics Market Cap

Protalix BioTherapeutics has a market cap or net worth of $142.35 million as of January 6, 2026. Its market cap has increased by 11.12% in one year.

• Market Cap: 142.35M
• Enterprise Value: 121.15M
• 1-Year Change: 11.12%
• Ranking: #4023
• Category: Micro-Cap
• Stock Price: $1.77

Market Cap Chart

Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $142.35M, an increase of 1,106.32%. That is a compound annual growth rate of 9.62%.

Market Cap History

Date	Market Cap	% Change
Jan 5, 2026	144.00M	-0.55%
Dec 31, 2025	144.80M	4.62%
Dec 31, 2024	138.40M	6.54%
Dec 29, 2023	129.90M	87.18%
Dec 30, 2022	69.40M	83.11%
Dec 31, 2021	37.90M	-68.68%
Dec 31, 2020	121.00M	148.46%
Dec 31, 2019	48.70M	5.64%
Dec 31, 2018	46.10M	-50.11%
Dec 29, 2017	92.40M	107.64%
Dec 30, 2016	44.50M	-56.29%
Dec 31, 2015	101.80M	-40.95%
Dec 31, 2014	172.40M	-52.64%
Dec 31, 2013	364.00M	-24.96%
Dec 31, 2012	485.10M	14.93%
Dec 30, 2011	422.10M	-47.92%
Dec 31, 2010	810.50M	58.46%
Dec 31, 2009	511.50M	266.14%
Dec 31, 2008	139.70M	-45.71%
Dec 31, 2007	257.30M	2,552.58%
Dec 29, 2006	9.70M	-21.77%
Dec 30, 2005	12.40M	1,671.43%
Dec 31, 2004	700.00K	-41.67%
Dec 31, 2003	1.20M	300.00%
Dec 31, 2002	300.00K	-57.14%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	967.33B
Johnson & Johnson	499.57B
AbbVie	405.28B
UnitedHealth Group	304.72B
AstraZeneca	284.35B
Novartis AG	266.00B
Merck & Co.	264.21B
Novo Nordisk	230.76B